Navigation Links
Acute Pain Global Clinical Trials Review, H2, 2013
Date:11/27/2013

tics 39
Cubist Pharmaceuticals, Inc. 40
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 40
Shire Plc 41
Clinical Trial Overview of Shire Plc 41
AcelRx Pharmaceuticals, Inc. 42
Clinical Trial Overview of AcelRx Pharmaceuticals, Inc. 42
Luitpold Pharmaceuticals, Inc. 43
Clinical Trial Overview of Luitpold Pharmaceuticals, Inc. 43
IPCA Laboratories Limited 44
Clinical Trial Overview of IPCA Laboratories Limited 44
Grunenthal GmbH 45
Clinical Trial Overview of Grunenthal GmbH 45
Troikaa Pharmaceuticals Ltd. 46
Clinical Trial Overview of Troikaa Pharmaceuticals Ltd. 46
Wockhardt UK Holdings Limited 47
Clinical Trial Overview of Wockhardt UK Holdings Limited 47
Ardent Pharmaceuticals Inc 48
Clinical Trial Overview of Ardent Pharmaceuticals Inc 48
A. Menarini AG 49
Clinical Trial Overview of A. Menarini AG 49
AbbVie Inc. 50
Clinical Trial Overview of AbbVie Inc. 50
Mallinckrodt plc 51
Clinical Trial Overview of Mallinckrodt plc 51
Clinical Trial Overview of Top Institutes / Government 52
Montefiore Medical Center 52
Clinical Trial Overview of Montefiore Medical Center 52
Tehran University of Medical Sciences 53
Clinical Trial Overview of Tehran University of Medical Sciences 53
University Hospital, Toulouse 54
Clinical Trial Overview of University Hospital, Toulouse 54
Ahvaz Jundishapur University of Medical Sciences 55
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 55
The Samueli Institute 56
Clinical Trial Overview of The Samueli Institute 56
The University of Sydney 57
Clinical Trial Overview of The University of Sydney 57
Ullevaal University Hospital 58
Clinical Trial Overview of Ullevaal University Hospital 58
Leiden University Medical Center 59
Clin
'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
2. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
3. Start of Phase IIa Study in Acute Lung Injury Patients Marks Development Milestone
4. MarketsandMarkets: Acute Myeloid Leukemia Therapeutics Market in G8 Countries Worth $1.67 Billion by 2020
5. CSL Behring Study Confirms Early Treatment with Berinert® Provides Faster Resolution of Acute Hereditary Angioedema Symptoms
6. Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine
7. Acute Lymphocytic Leukemia: Impressive Results With the Monoclonal Antibody Blinatumomab in Patients With Refractory Disease
8. Study of Cell Therapeutics Tosedostat for Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Now Enrolling
9. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
10. Global Acute Myeloid Leukemia (AML) Therapeutics Industry
11. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 1, 2015  Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced today ... second tranche of a $40 million investment from Woodford ... first invested $25 million in NW Bio on November ... an agreement with the Company for a further $40 ...
(Date:5/1/2015)... 01, 2015 OncoTAb, Inc., ... spin-out company, announced that Pinku Mukherjee, Ph.D. has received ... Board of Governors’ highest faculty honor. Mukherjee received the ... , for her innovative research and development of cancer ... represents a crowning moment in my scientific career,” said ...
(Date:5/1/2015)... , May 1, 2015 /PRNewswire/ - BioAmber Inc. ... sustainable chemicals, today announced that it has priced an underwritten ... at a price of $9.00 per share, and granted ... purchase up to an additional 585,000 shares of its ... be $35.1 million.  The offering is expected to close on ...
(Date:5/1/2015)... 1, 2015 Pfenex Inc. (NYSE MKT: ... development of biosimilar therapeutics including high value and ... first quarter 2015 financial results will be released ... of market. At 8:30 am Eastern Time, Pfenex management ... financial results and provide a business update. A press ...
Breaking Biology Technology:NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 2NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 3OncoTAb CSO Awarded the University of North Carolina’s O. Max Gardner Award 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 3Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2
... An information technology,revolution is improving cancer treatment ... to Supportive Oncology Services, Inc. (SOS), a,research-based ... are self-,assessments that measure any aspect relating ... patient without any interpretation by the healthcare,team. ...
... March 24 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX:,MS), a ... today,announced that Mr. Kevin Giese, President and CEO, will ... Conference in New York., WHEN: ... The Millennium Broadway Hotel & Conference Center, New ...
... Ontario, March 24 Odor-fighting, RepHresh,Vaginal Gel(R) is now ... for candor and a mission to educate women about ... and,not pulling punches when it comes to discussing a ... the U.S., RepHresh has created a successful dialogue between ...
Cached Biology Technology:Patient-Reported Outcomes (PROs) Improve Cancer Treatment -- Experts Agree 2Patient-Reported Outcomes (PROs) Improve Cancer Treatment -- Experts Agree 3BioMS Medical to present at BioCentury Conference 2pH Balanced RepHresh Vaginal Gel(R) now Available to Women in Canada Attacking Tough, Embarrassing Feminine Issues 2pH Balanced RepHresh Vaginal Gel(R) now Available to Women in Canada Attacking Tough, Embarrassing Feminine Issues 3
(Date:4/27/2015)... , April 27, 2015  For more than four ... show has been the premier worldwide event for the ... is a must-attend event for any local, national, or ... the emerging commercial markets and current applications of unmanned ... of this projected $48 billion industry, and how it ...
(Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
(Date:4/27/2015)... 2015 Profile Solutions, Inc. (OTC: PSIQ), a ... is pleased to announce that Dr Gerry Bedore ... member of its scientific advisory board. ... thought leader in technology-enhanced learning models. He was a ... published studies and books focused on online student success ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... has developed the first small molecule that can reversibly ... paving the way for drugs that can treat low ... epithelial sodium channel (ENaC) controls sodium flow across many ... it is vital to maintaining proper salt balance and ...
... patients around the world following a routine dosage of ... frantic search to uncover what could make the standard ... was among a small group of scientists with the ... source of the contamination. Robert J. Linhardt, ...
... Mothers born in India and Sri Lanka are three ... vomiting in pregnancy (hyperemesis gravidarum) than ethnic Norwegians. This ... study of 900, 000 first-time pregnancies registered in the ... period. Earlier studies reported that 90 percent ...
Cached Biology News:Deadly dose: Rensselaer heparin expert helps uncover source of lethal contamination 2Extreme nausea and vomiting varies among pregnant women from different countries 2
20X TE buffer *RNase free*...
...
MOUSE ANTI HUMAN MOC31:AZIDE FREE...
... and flexibility press-to-seal silicone isolators can be ... researcher. They are available either pre-cut to ... that can be easily trimmed to prepare ... non-cytotoxic and can be used to isolate ...
Biology Products: